Breaking News, Financial News

AMRI

Development/Small Scale revenues show first growth since 4Q08

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 4Q10 4Q Revenues: $48.6 million (+12%) 4Q Loss: $49.1 million (loss of $19.2 million in 4Q09) FY Revenues: $198.1 million (+1%) FY Loss: $62.9 million (loss of 16.7 million in FY09) Comments: Contract revenues rose 16% in 4Q10 to $40.7 million, including a 48% bump in Large Scale Manufacturing to $19.1 million. Development/Small Scale Manufacturing revenues were up 12% to $10.5 million, marking the first quarter since 4Q08 to show growth. Discovery services dropped 13% to $11...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters